
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)
Keywords: FAAH inhibitors; Pyrazole phenylcyclohexylcarbamate; Molecular modeling; Reversibility; FAAH; fatty acid amide hydrolase; hrFAAH; human recombinant fatty acid amide hydrolase; MAGL; monoacylglycerol lipase; NAEs; N-acyl-ethanolamines; MAGs; monoacylglycer